Enterome
Clinical trials sponsored by Enterome, explained in plain language.
-
Gut bacteria vaccine takes on colorectal cancer remnants
Disease control TerminatedThis study tested a new vaccine (EO2040) made from gut bacteria, combined with the immunotherapy drug nivolumab, in people with colorectal cancer who had tiny amounts of cancer DNA left in their blood after standard treatment. The goal was to see if the combination could clear th…
Phase: PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated May 26, 2026 08:48 UTC
-
Experimental vaccine trial for rare adrenal cancers halted early
Disease control TerminatedThis early-stage trial tested a new therapeutic vaccine (EO2401) combined with immune-boosting drugs in 70 people with advanced adrenal gland cancers (adrenocortical carcinoma or malignant pheochromocytoma/paraganglioma). The goal was to see if the combination was safe and could …
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated May 26, 2026 08:41 UTC